Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett Collinge

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Blood Advances|April 15, 2026
LySeqST: A targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphomaLaura K Hilton, Sierra Gillis, Faraneh Yahyaei-Moayyed, et al.
Blood|October 29, 2020
The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHCBrett Collinge, Susana Ben-Neriah, Lauren Chong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell LymphomaDaisuke Ennishi, Aixiang Jiang, Merrill Boyle, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Relapse timing is associated with distinct evolutionary dynamics in DLBCLLaura K Hilton, Henry S Ngu, Brett Collinge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2023
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell LymphomaLaura K Hilton, Henry S Ngu, Brett Collinge, et al.
Cancer Cell|January 12, 2024
Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagyJames D Phelan, Sebastian Scheich, Jaewoo Choi, et al.
Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
High-grade B-cell lymphoma, not otherwise specified: an LLMPP studyBrett Collinge, Laura K Hilton, Jasper Wong, et al.
Blood|May 3, 2024
Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study)Laura K Hilton, Brett Collinge, Susana Ben-Neriah, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Blood Advances|April 15, 2026
LySeqST: A targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphomaLaura K Hilton, Sierra Gillis, Faraneh Yahyaei-Moayyed, et al.
Blood|October 29, 2020
The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHCBrett Collinge, Susana Ben-Neriah, Lauren Chong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell LymphomaDaisuke Ennishi, Aixiang Jiang, Merrill Boyle, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Relapse timing is associated with distinct evolutionary dynamics in DLBCLLaura K Hilton, Henry S Ngu, Brett Collinge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2023
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell LymphomaLaura K Hilton, Henry S Ngu, Brett Collinge, et al.
Cancer Cell|January 12, 2024
Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagyJames D Phelan, Sebastian Scheich, Jaewoo Choi, et al.
Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
High-grade B-cell lymphoma, not otherwise specified: an LLMPP studyBrett Collinge, Laura K Hilton, Jasper Wong, et al.
Blood|May 3, 2024
Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study)Laura K Hilton, Brett Collinge, Susana Ben-Neriah, et al.
Pageof 2